CN105683152B - 用于治疗高血压和/或纤维化的组合物 - Google Patents

用于治疗高血压和/或纤维化的组合物 Download PDF

Info

Publication number
CN105683152B
CN105683152B CN201480050979.1A CN201480050979A CN105683152B CN 105683152 B CN105683152 B CN 105683152B CN 201480050979 A CN201480050979 A CN 201480050979A CN 105683152 B CN105683152 B CN 105683152B
Authority
CN
China
Prior art keywords
fibrosis
treatment
pharmaceutically acceptable
hypertension
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480050979.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN105683152A (zh
Inventor
凯伦·安妮特·达根
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Pty Ltd
Original Assignee
Vectus Biosystems Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Publication of CN105683152A publication Critical patent/CN105683152A/zh
Application granted granted Critical
Publication of CN105683152B publication Critical patent/CN105683152B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201480050979.1A 2013-09-17 2014-09-17 用于治疗高血压和/或纤维化的组合物 Active CN105683152B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903573 2013-09-17
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis

Publications (2)

Publication Number Publication Date
CN105683152A CN105683152A (zh) 2016-06-15
CN105683152B true CN105683152B (zh) 2017-03-22

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480050979.1A Active CN105683152B (zh) 2013-09-17 2014-09-17 用于治疗高血压和/或纤维化的组合物

Country Status (22)

Country Link
US (1) US9458093B2 (OSRAM)
EP (1) EP3046901B1 (OSRAM)
JP (1) JP6122548B2 (OSRAM)
KR (1) KR101736416B1 (OSRAM)
CN (1) CN105683152B (OSRAM)
AP (1) AP2016009079A0 (OSRAM)
AU (1) AU2014324078B2 (OSRAM)
BR (1) BR112016005601B1 (OSRAM)
CA (1) CA2924356C (OSRAM)
DK (1) DK3046901T3 (OSRAM)
ES (1) ES2655455T3 (OSRAM)
IL (1) IL244621A (OSRAM)
MX (1) MX368865B (OSRAM)
MY (1) MY172557A (OSRAM)
NO (1) NO3046901T3 (OSRAM)
NZ (1) NZ717927A (OSRAM)
PH (1) PH12016500497B1 (OSRAM)
PL (1) PL3046901T3 (OSRAM)
RU (1) RU2635564C2 (OSRAM)
SG (1) SG11201601642WA (OSRAM)
UA (1) UA118111C2 (OSRAM)
WO (1) WO2015039173A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
DK3271326T3 (da) * 2015-03-18 2021-01-25 Vectus Biosystems Ltd Sammensætninger til behandling af nyre- og/eller leversygdom
WO2016145479A1 (en) * 2015-03-18 2016-09-22 Vectus Biosystems Limited Compositions for the treatment of fibrosis and fibrosis-related conditions
ES2861434T3 (es) 2015-09-22 2021-10-06 Vectus Biosystems Ltd Síntesis de compuestos terfenilo
KR102508022B1 (ko) * 2016-04-13 2023-03-10 보드 오브 리젠츠 오브 디 유니버시티 오브 네브라스카 레시니페라톡신을 사용한 투여 방법 및 심혈관 질환을 치료하는 방법
EP3490970B1 (en) * 2016-07-28 2023-09-13 Vectus Biosystems Limited Compositions for the treatment of pulmonary fibrosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1993137A (zh) * 2004-06-11 2007-07-04 维克特斯生物系统有限公司 用于治疗心血管疾病的组合物和方法
US20110082109A1 (en) * 2009-10-02 2011-04-07 Ajinomoto Co., Inc. Novel acyl guanidine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694288B1 (fr) * 1992-06-30 1994-09-09 Rhone Poulenc Agrochimie Phenylbenzamides fongicides et procédés pour les préparer.
AU2006322656B2 (en) * 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
AP2016009080A0 (en) * 2013-09-17 2016-03-31 Vectus Biosystems Pty Ltd Compositions for the treatment of hypertension and/or fibrosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1993137A (zh) * 2004-06-11 2007-07-04 维克特斯生物系统有限公司 用于治疗心血管疾病的组合物和方法
US20110082109A1 (en) * 2009-10-02 2011-04-07 Ajinomoto Co., Inc. Novel acyl guanidine derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A modular synthesis of teraryl-based a-helix mimetics, part 1:synthesis of core fragments with two electronically differentiated leaving groups;Martin Peters et al;《Chem.Eur.J.》;20130104;第19卷;2442-2449 *

Also Published As

Publication number Publication date
CN105683152A (zh) 2016-06-15
AU2014324078A1 (en) 2016-04-07
MX2016003371A (es) 2016-10-21
UA118111C2 (uk) 2018-11-26
PL3046901T3 (pl) 2018-03-30
CA2924356A1 (en) 2015-03-26
MX368865B (es) 2019-08-02
RU2016112257A (ru) 2017-10-20
IL244621A0 (en) 2016-04-21
ES2655455T3 (es) 2018-02-20
JP6122548B2 (ja) 2017-04-26
KR20160074471A (ko) 2016-06-28
SG11201601642WA (en) 2016-04-28
WO2015039173A1 (en) 2015-03-26
CA2924356C (en) 2018-04-03
BR112016005601B1 (pt) 2021-02-02
US9458093B2 (en) 2016-10-04
EP3046901B1 (en) 2017-10-18
IL244621A (en) 2017-04-30
JP2016532632A (ja) 2016-10-20
KR101736416B1 (ko) 2017-05-16
RU2635564C2 (ru) 2017-11-14
EP3046901A1 (en) 2016-07-27
EP3046901A4 (en) 2017-04-12
DK3046901T3 (en) 2018-01-02
NO3046901T3 (OSRAM) 2018-03-17
AU2014324078B2 (en) 2016-12-15
PH12016500497A1 (en) 2016-06-13
BR112016005601A8 (pt) 2020-02-18
PH12016500497B1 (en) 2017-12-13
NZ717927A (en) 2018-12-21
US20160221933A1 (en) 2016-08-04
MY172557A (en) 2019-12-02
AP2016009079A0 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
CN105683152B (zh) 用于治疗高血压和/或纤维化的组合物
RU2659784C2 (ru) Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
JP6608404B2 (ja) 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法
WO1997009977A1 (fr) Inhibiteur specifique de cyclo-oxygenase 2 et agent anti-inflammatoire
JP6293266B2 (ja) 高血圧及び／又は線維症の処置用組成物
EP3458448A1 (en) Methods of using fasn inhibitors
WO2024060912A1 (zh) 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物
TW201544108A (zh) 異喹啉生物鹼衍生物用於製備促進ａｍｐｋ活性的藥物之用途
CN113402444B (zh) 一种咔唑类化合物及其在制备治疗脂肪肝及2型糖尿病等代谢相关疾病药物中的应用
US20210346331A1 (en) Trpv4 activity inhibitor
US10183908B2 (en) Compositions for the treatment of kidney and/or liver disease
HK1226324A1 (en) Compositions for the treatment of hypertension and/or fibrosis
HK1226324B (en) Compositions for the treatment of hypertension and/or fibrosis
CN101811974B (zh) 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
TR2021022296A2 (tr) Ti̇p 2 diabetes mellitus hastaliğinin tedavi̇si̇ i̇çi̇n bi̇r i̇laç ve bu i̇lacin nanoparti̇külü
JP2024522030A (ja) フェノキシアルキルカルボン酸誘導体、およびトリグリセリドレベルを低下させることにおけるその使用
JPWO2014030624A1 (ja) スチルベン誘導体を有効成分として含有する筋緊張性ジストロフィー治療剤
CN107417669A (zh) 3-(1h-吲唑)-四氢嘧啶-2-酮类化合物、其制备方法及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant